XCUR - EXICURE, INC.

3.64
0.002   0.055%

Share volume: 85,081
Last Updated: 04-23-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.16%

PREVIOUS CLOSE
CHG
CHG%
$3.64
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
22%
Profitability 25%
Dept financing 6%
Liquidity 50%
Performance 15%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-3.40%
1 Month
-18.57%
3 Months
-27.92%
6 Months
-27.20%
1 Year
-67.31%
2 Year
606.80%
Key data
Stock price
$3.64
P/E Ratio 
N/A
DAY RANGE
$3.55 - $3.70
EPS 
-$0.77
52 WEEK RANGE
$3.10 - $11.86
52 WEEK CHANGE
-$66.30
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
6.374 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
06-16-2025
BETA 
5.12
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$21,393
AVERAGE 30 VOLUME 
$16,457
Company detail
CEO: Matthias G. Schroff
Region: US
Website: exicuretx.com
Employees: 50
IPO year: 2018
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Exicure, Inc. develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. The company has a collaboration, option, and license agreement with AbbVie Inc. to develop SNA-based treatments for hair loss disorders.

Recent news